MARKER THERAPEUTICS, INC. Increase (Decrease) in Accrued Interest Receivable, Net
MARKER THERAPEUTICS, INC. (MRKR) reported Increase (Decrease) in Accrued Interest Receivable, Net of -$681.55 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2025-11-13
- MARKER THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-09-30 was -$9.18K.
- MARKER THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-06-30 was -$784.43K, a 222.82% decline year-over-year.
- MARKER THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-03-31 was $112.06K, a 86.39% decline year-over-year.
- MARKER THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2024-12-31 was $1.60M, a 69.64% increase year-over-year.
- MARKER THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2024 was $1.32M.
- MARKER THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2023 was -$1.37M, a 157.22% decline from fiscal 2022.
- MARKER THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2022 was $2.40M.
- MARKER THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2021 was -$1.00M.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$9.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$793.61K derived: sum of 2 quarters · filed 2025-11-13 | -$681.55K 10-Q · filed 2025-11-13 | $920.74K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | -$784.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$672.37K 10-Q · filed 2025-08-14 | $929.92K derived: sum of 3 quarters · filed 2025-08-14 | -$815.81K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $112.06K 10-Q · filed 2025-05-15 | $1.71M derived: sum of 2 quarters · filed 2025-05-15 | -$31.38K derived: sum of 3 quarters · filed 2025-11-13 | $607.30K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$143.44K derived: sum of 2 quarters · filed 2025-11-13 | $495.24K derived: sum of 3 quarters · filed 2025-11-13 | $1.32M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.11M derived: sum of 2 quarters · filed 2025-11-13 | -$283.40K 10-Q · filed 2025-11-13 | $661.10K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $638.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.46M 10-Q · filed 2025-08-14 | $2.41M derived: sum of 3 quarters · filed 2025-08-14 | $744.05K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $823.65K 10-Q · filed 2025-05-15 | $1.77M derived: sum of 2 quarters · filed 2025-05-15 | $105.36K derived: sum of 3 quarters · filed 2025-05-15 | $768.58K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $944.50K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$718.28K derived: sum of 2 quarters · filed 2025-03-31 | -$55.07K derived: sum of 3 quarters · filed 2025-03-31 | -$1.37M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$999.57K derived: sum of 2 quarters · filed 2024-11-14 | -$2.32M 10-Q · filed 2024-11-14 | -$1.60M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $663.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$655.90K 10-Q · filed 2024-08-14 | $65.08K derived: sum of 3 quarters · filed 2024-08-14 | $1.12M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$1.32M 10-Q · filed 2024-05-15 | -$598.13K derived: sum of 2 quarters · filed 2024-05-15 | $455.26K derived: sum of 3 quarters · filed 2024-05-15 | $1.08M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $720.99K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $1.77M derived: sum of 2 quarters · filed 2024-03-26 | $2.40M derived: sum of 3 quarters · filed 2024-03-26 | $2.40M 10-K · filed 2024-03-26 |
| 2022-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.68M derived: sum of 2 quarters · filed 2023-08-14 | $1.68M 10-Q · filed 2022-11-10 | $1.68M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $625.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $627.39K 10-Q · filed 2023-08-14 | $627.39K derived: sum of 3 quarters · filed 2023-08-14 | $627.34K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.95K 10-Q · filed 2023-05-15 | $1.94K derived: sum of 2 quarters · filed 2023-05-15 | $1.90K derived: sum of 3 quarters · filed 2023-05-15 | -$998.68K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$6.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$49.00 derived: sum of 2 quarters · filed 2023-03-22 | -$1.00M derived: sum of 3 quarters · filed 2023-03-22 | -$1.00M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$43.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.00M derived: sum of 2 quarters · filed 2022-11-10 | -$1.00M 10-Q · filed 2022-11-10 | -$999.89K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.00M 10-Q · filed 2022-08-11 | -$999.85K derived: sum of 3 quarters · filed 2022-08-11 | -$1.00M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $308.00 10-Q · filed 2022-05-13 | $732.00 derived: sum of 2 quarters · filed 2022-05-13 | -$2.57K derived: sum of 3 quarters · filed 2022-05-13 | -$23.74K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $424.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$2.88K derived: sum of 2 quarters · filed 2022-03-17 | -$24.05K derived: sum of 3 quarters · filed 2022-03-17 | -$55.63K 10-K · filed 2022-03-17 |
| 2020-09-30 | -$3.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$24.47K derived: sum of 2 quarters · filed 2021-11-10 | -$56.05K 10-Q · filed 2021-11-10 | -$78.01K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$21.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$52.75K 10-Q · filed 2021-08-10 | -$74.70K derived: sum of 3 quarters · filed 2021-08-10 | -$94.71K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$31.58K 10-Q · filed 2021-05-12 | -$53.54K derived: sum of 2 quarters · filed 2021-05-12 | -$73.55K derived: sum of 3 quarters · filed 2021-05-12 | -$87.59K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$21.96K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$41.97K derived: sum of 2 quarters · filed 2021-03-09 | -$56.01K derived: sum of 3 quarters · filed 2021-03-09 | -$51.99K 10-K · filed 2021-03-09 |
| 2019-09-30 | -$20.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$34.05K derived: sum of 2 quarters · filed 2020-11-09 | -$30.03K 10-Q · filed 2020-11-09 | $78.14K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$14.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$10.02K 10-Q · filed 2020-08-10 | $98.15K derived: sum of 3 quarters · filed 2020-08-10 | $98.15K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $4.02K 10-Q · filed 2020-05-11 | $112.20K derived: sum of 2 quarters · filed 2020-05-11 | $112.20K derived: sum of 3 quarters · filed 2020-05-11 | $112.20K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $108.18K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $108.18K derived: sum of 2 quarters · filed 2020-03-12 | $108.18K derived: sum of 3 quarters · filed 2020-03-12 | $108.18K 10-K · filed 2020-03-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |